The AIDS Reader: AIDS and HIV News and Information
The good news: the HIV population is aging.
When -- and how -- to treat patients co-infected with TB and HIV? Insights here.
PrEP is likely to be cost-effective, regardless of which regimen, or which route, is used. Here: the latest from CROI.
A new study suggests that cognitive impairments in older HIV-infected individuals may be even more prevalent than previously thought.
Do you know which patients would benefit from PrEP? The CDC reports that many American adults who could benefit from HIV prophylaxis aren't receiving treatment.
Here's why you need to keep bone disease in mind when choosing an antiretroviral regimen for your patients with HIV -- and guidance about selecting therapy.
Depression is a major barrier to HIV care. But depression treatment can significantly reduce depressive severity--and improve HIV outcomes. Details here.
News from the CDC: men who have sex with men should be targeted for high-frequency HIV testing.